MUMBAI (Reuters) - Natco Pharma Ltd said on Monday it has agreed a deal with Gilead Sciences Inc to supply generic copies of the U.S. drugmaker's chronic hepatitis C medicines, including $1,000-a-pill ...

The patent in question is due to lapse in March next year. The court is scheduled to take up Natco's challenge for further hearing in February ...

HOUSTON, July 20 /PRNewswire-FirstCall/ -- NATCO Group Inc. (NYSE: NTG) announced today that it has sold shares representing twenty-five percent ownership in its ...

West Warwick, RI – Natco Home is wrapping up the finishing touches on the recent revamp of its headquarters showroom just in time for market week, which kicks off March 22. “We’re all set up and ready ...

WEST WARWICK, R.I. — Rug manufacturer Natco Home announced that Nina Bostick has been appointed vice president of sales and product development, effective June 1. Bostick brings 25 years of experience ...

Natco Pharma announced that through its affiliates it is proposing to enter into an agreement to acquire Dash Pharmaceuticals subject to satisfactory completion of due diligence, execution of ...

Natco Pharma Ltd shares continued their sharp fall in Friday's trade after the company recorded a drop in its third-quarter results. The stock plunged 10.80 per cent to hit a 52-week low of Rs 868.25.

Yet another Indian drugmaker has had plants written up by the FDA for not hitting manufacturing standards. This time it is Natco Pharma, which said it got Form 483s for its pharmaceutical formulations ...

Natco Pharma’s glycopyrrolate tablets, a generic version of the brand name drug Robinul, are used in conjunction with other medications to treat peptic ulcers. The tablets block the activity of ...

Generics player Natco Pharma has already made plenty of waves in the Indian pharma market with cheaper versions of blockbuster meds, playing by a patent challenge strategy that's ignited the ire of ...

Total Revenue (FY25): INR 4,784 crores, up 16% from INR 4,126.9 crores in FY24. Net Profit (FY25): INR 1,883.4 crores, a 36% increase from INR 1,388.3 crores in the previous year. Q4 Revenue: INR ...

Natco Pharma share price: At close, shares of Natco Pharma stood at Rs 1,027 apiece, up 15.8 per cent, or Rs 1,40.15. Representative image. Source: Pexels Natco Pharma share price: Shares of Natco ...